ASCO GI 2026: vídeos e entrevistas
36 vídeos do ASCO GI 2026 publicados por ASCO Podcasts, Oncology Brothers, VJOncology. Atualizado em 20/11/2026.
Patient-centered care and clinical trial needs in appendix cancerVJOncology · 24/03/2026 · 1:19 · apoio da indústria
Disease biology and treatment challenges in appendix cancerVJOncology · 24/03/2026 · 1:04 · apoio da indústria
Optimizing treatment with perioperative chemotherapy in gastric cancerVJOncology · 23/03/2026 · 1:46 · apoio da indústria
Current role of radiotherapy in gastric cancer and selective post-op useVJOncology · 23/03/2026 · 1:23 · apoio da indústria
Immunotherapy in hepatocellular carcinoma with impaired liver functionVJOncology · 23/03/2026 · 2:22 · apoio da indústria
Adjuvant immunotherapy in HCC and risk stratification challengesVJOncology · 23/03/2026 · 1:27 · apoio da indústria
Patient selection and design of the STOPGAP II trial in gastric cancerVJOncology · 23/03/2026 · 4:07 · apoio da indústria
STOPGAP: iterative intraperitoneal paclitaxel and chemotherapy in G/GEJAVJOncology · 23/03/2026 · 3:17 · apoio da indústria
Phase 2 trial of cabozantinib, ipilimumab, nivolumab, and TACE in HCCVJOncology · 18/03/2026 · 1:22 · apoio da indústria
Trans-arterial tirapazamine embolization and pembrolizumab in HCCVJOncology · 18/03/2026 · 2:11 · apoio da indústria
Comprehensive biomarker testing and heterogeneity in gastric cancerVJOncology · 18/03/2026 · 2:16 · apoio da indústria
LUCERNA: zolbetuximab, pembrolizumab, and chemotherapy in gastric cancerVJOncology · 18/03/2026 · 1:31 · apoio da indústria
HERIZON-GEA-01: zanidatamab ± tislelizumab & chemotherapy for HER2+ GEAVJOncology · 18/03/2026 · 4:16 · apoio da indústria
Highlights From the 2026 ASCO GI Cancers SymposiumASCO Podcasts · 26/01/2026 · 20:21
ASCO GI 2026 takeawaysVJOncology · 15/01/2026 · 1:10 · apoio da indústria
Highlights from ASCO GI 2026: HERIZON-GEA-01, ILUSTRO & BREAKWATERVJOncology · 15/01/2026 · 4:10 · apoio da indústria
Neoadjuvant epacadostat with short course radiotherapy in pts with locally advanced rectal cancerVJOncology · 15/01/2026 · 1:33 · apoio da indústria
Phase II trial of early-line anti-EGFR therapy to facilitate retreatment for patients with mCRCVJOncology · 15/01/2026 · 1:49 · apoio da indústria
Early genomic profiling in pancreatic cancer: matching biomarkers to neoadjuvant therapyVJOncology · 15/01/2026 · 1:31 · apoio da indústria
Associations of 9p21 deletions on chemo outcomes in pancreatic ductal adenocarcinomaVJOncology · 15/01/2026 · 1:20 · apoio da indústria
AI-powered analysis examining mode of presentation and symptoms of colorectal cancerVJOncology · 15/01/2026 · 1:50 · apoio da indústria
Strategies to overcome the immunologically "cold" tumor microenvironment of MSS CRCVJOncology · 15/01/2026 · 1:24 · apoio da indústria
OS of immunotherapy vs SOC in microsatellite stable metastatic colorectal cancerVJOncology · 15/01/2026 · 2:41 · apoio da indústria
Patient voice essential for research trial design and treatment developmentVJOncology · 15/01/2026 · 1:11 · apoio da indústria
Early onset colorectal cancer: unique challenges for younger patientsVJOncology · 15/01/2026 · 2:01 · apoio da indústria
Early-onset colorectal cancer: awareness, testing, & research priorities of survivors and caregiversVJOncology · 15/01/2026 · 1:58 · apoio da indústria
ctDNA adoption in the US: sensitivity limitations and cost barriers remainVJOncology · 15/01/2026 · 1:11 · apoio da indústria
ctDNA as prognostic marker in CRC: high predictive value, assay limitationsVJOncology · 15/01/2026 · 1:08 · apoio da indústria
Minimal residual disease (MRD) trials in colorectal cancerVJOncology · 15/01/2026 · 1:54 · apoio da indústria
GI ASCO 2026 Highlights MATTERHORN, HERIZON-GEA-01, BREAKWATER, COMMIT – Dr. Rachna ShroffOncology Brothers · 15/01/2026 · 21:34 · apoio da indústria
Optimising first-line treatment in gastric cancer through precision medicineVJOncology · 09/01/2026 · 2:50 · apoio da indústria
KEYSTEP-008: pembro-based combinations for MSI-H/dMMR mCRCVJOncology · 09/01/2026 · 3:11 · apoio da indústria
KEYNOTE-937: adjuvant pembro for pts with HCC after surgical resection/local ablationVJOncology · 09/01/2026 · 1:29 · apoio da indústria
Phase II ILUSTRO: 1L zolbetuximab + mFOLFOX6 + nivolumab in CLDN18.2+ mG/GEJ cancerVJOncology · 09/01/2026 · 2:54 · apoio da indústria
HERIZON-GEA-01: zanidatamab + chemotherapy +/- tislelizumab improves PFS in 2L HER2+ mGEAVJOncology · 09/01/2026 · 3:46 · apoio da indústria
CRITICS-II: comparing neoadjuvant chemo, chemoradiotherapy, and surgery in gastric cancerVJOncology · 08/01/2026 · 2:13 · apoio da indústria